As ginsenosides target the central nervous system (CNS), which regulates leptin sensitivity in the cerebral cortex to prevent obesity and decreases the risk of central inflammation in the hypothalamus (Jeon et al., 2021). This evidence concerns the gene LEP and obesity disorder.